Tag Archives: trial

NIH ‘very concerned’ about serious side effect in AstraZeneca coronavirus vaccine trial

“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.” A great deal… Read More: NIH ‘very concerned’ about serious side effect in AstraZeneca coronavirus… »

The Paradigm Shift That Wasn’t: The ISCHEMIA Trial

By ANISH KOKA A recent email that arrived in my in-box a few weeks ago from an academic hailed the latest “paradigm shift” in cardiology as it relates to the management of stable angina. (Stable angina refers to chronic,non-accelerating chest pain with a moderate level of exertion). The points made in the email were as… Read More: The Paradigm Shift That Wasn’t: The ISCHEMIA Trial »

Early Trial Offers New Hope for People With Hemophilia

WEDNESDAY, Sept. 9, 2020 — Researchers may have found a way for people with severe hemophilia to take their standard treatment less often, if the results of an early trial pan out. In what experts called a feat of bioengineering, scientists were able to create a “fusion protein” that may extend the interval between treatments… Read More: Early Trial Offers New Hope for People With Hemophilia »

ESC: Eli Lilly, Boehringer’s Jardiance cuts CV events by 25% in Farxiga-matching heart failure trial

AstraZeneca put the rest of the SGLT2 inhibitor class on notice when its Farxiga scored an FDA heart failure nod in patients with or without diabetes. One of its competitors, Eli Lilly and Boehringer Ingelheim’s Jardiance, is fast on Farxiga’s heels, though, and it’s ready to bring its pivotal trial win in front of physicians. Jardiance, added… Read More: ESC: Eli Lilly, Boehringer’s Jardiance cuts CV events by 25%… »